Luminal Malignancy Day. The event, organized by Dept of Surgery in collaboration with the Department of Radiation and Medical Oncology,

Government Medical College (GMC) Srinagar recently marked a significant milestone in its ongoing commitment to combat gastrointestinal cancers with the inaugural Luminal Malignancy Day. The event, organized in collaboration with the Department of Radiation and Medical Oncology, highlighted cutting-edge advancements in the treatment of luminal malignancies.

Led by Professor Iqbal Saleem Mir, the Head of the Department of Surgery, the day showcased a series of advanced laparoscopic surgeries targeting various gastrointestinal cancers. These surgeries not only demonstrated the expertise of the medical faculty but also underscored the institution’s dedication to providing patients with minimally invasive yet highly effective treatment options.

The Luminal Malignancy Day was more than just a surgical showcase; it was a platform for interdisciplinary collaboration. Experts from surgery, radiation oncology, medical oncology, and the PG department of anesthesia came together to discuss and implement comprehensive care plans for patients, ensuring they receive tailored treatment from diagnosis to recovery.

Live demonstrations of laparoscopic procedures allowed attendees to witness firsthand the precision and innovation driving modern surgical techniques. Professor Iqbal Saleem Mir expressed his gratitude to the entire medical team for their efforts in making the event a success and stressed the importance of collaborative efforts in advancing patient care and medical education.

Professor Iffat Hassan Shah, the Principal of Government Medical College Srinagar, praised the initiative, recognizing it as a significant step forward in addressing the challenges posed by gastrointestinal cancers. By fostering collaboration among different specialties, the institution aims to improve patient outcomes and provide state-of-the-art care.

As Government Medical College Srinagar looks to the future, it remains steadfast in its mission to lead the fight against cancer, pushing the boundaries of medical innovation, and offering hope and healing to individuals and families affected by luminal malignancies.